2 October 2026
Sidley Represents Pyxis Oncology in an up to US$282.6 Million Public Offering
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Asher Rubin Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Istvan Hajdu Lead | Sidley | Not stated | Capital Markets | Not stated |
| Henry Dickinson | Sidley | Not stated | Capital Markets | Not stated |
| Eric Carlson | Sidley | Not stated | Capital Markets | Not stated |
| Torrey Cope | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Lauren Limbach | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Dan Altman | Sidley | Not stated | Tax | Not stated |
| Ryan Kelly | Sidley | Not stated | Tax | Not stated |
5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 283m (US$282.6 Million)
- What the figure measures
- Total transaction value
- Client
- Pyxis Oncology, Inc.Issuer
- Counterparties
- Not stated